AMPLI — Amplitude Surgical SA Income Statement
0.000.00%
Last trade - 00:00
- €139.26m
- €218.83m
- €100.20m
- 43
- 71
- 41
- 50
2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 103 | 88.3 | 82.7 | 87.6 | 100 |
Cost of Revenue | |||||
Gross Profit | 83.5 | 66.3 | 64.3 | 67.6 | 79.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 103 | 91.1 | 84.4 | 82.6 | 92.2 |
Operating Profit | -0.704 | -2.83 | -1.65 | 4.94 | 8.05 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.74 | -11.3 | -11.7 | -1.63 | -6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.4 | -14.6 | -14.7 | -4.79 | 38.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -8.99 | -14.2 | -14.1 | -4.39 | 39.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.99 | -14.2 | -14.1 | -4.39 | 39.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.184 | -0.287 | -0.29 | -0.078 | 0.771 |
Dividends per Share |